These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 16103711)

  • 1. Mycobacterial gene cloning and expression, comparative genomics, bioinformatics and proteomics in relation to the development of new vaccines and diagnostic reagents.
    Mustafa AS
    Med Princ Pract; 2005; 14 Suppl 1():27-34. PubMed ID: 16103711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatics: how it is being used to identify bacterial vaccine candidates.
    Zagursky RJ; Olmsted SB; Russell DP; Wooters JL
    Expert Rev Vaccines; 2003 Jun; 2(3):417-36. PubMed ID: 12903807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant and synthetic peptides to identify Mycobacterium tuberculosis antigens and epitopes of diagnostic and vaccine relevance.
    Mustafa AS
    Tuberculosis (Edinb); 2005; 85(5-6):367-76. PubMed ID: 16253561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A proteome-scale identification of novel antigenic proteins in Mycobacterium tuberculosis toward diagnostic and vaccine development.
    Li Y; Zeng J; Shi J; Wang M; Rao M; Xue C; Du Y; He ZG
    J Proteome Res; 2010 Sep; 9(9):4812-22. PubMed ID: 20690665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biotechnology in the development of new vaccines and diagnostic reagents against tuberculosis.
    Mustafa AS
    Curr Pharm Biotechnol; 2001 Jun; 2(2):157-73. PubMed ID: 11480420
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Mycobacterium tuberculosis genoma and production of a recombinant protein containing specific B and T cell antigenic determinants--new approaches to second generation antituberculosis vaccines.
    Colizzi V; Vismara D; D'Urso C; Mezzopreti MF; Lombardi G; Piccolella E; Damiani G; Marelli P; Campa M
    Z Erkr Atmungsorgane; 1989; 172(1):40-52. PubMed ID: 2467445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning, expression, and immunogenicity of novel fusion protein of Mycobacterium tuberculosis based on ESAT-6 and truncated C-terminal fragment of HSP70.
    Tebianian M; Hoseini AZ; Ebrahimi SM; Memarnejadian A; Mokarram AR; Mahdavi M; Sohrabi N; Taghizadeh M
    Biologicals; 2011 May; 39(3):143-8. PubMed ID: 21388826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of genomics on vaccine design.
    Scarselli M; Giuliani MM; Adu-Bobie J; Pizza M; Rappuoli R
    Trends Biotechnol; 2005 Feb; 23(2):84-91. PubMed ID: 15661345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a specific Mycobacterium tuberculosis protein able to activate T lymphocytes.
    Vismara D; Favaro M; Mariani F; Piccolella E; Colizzi V
    Ann Ist Super Sanita; 1991; 27(1):21-6. PubMed ID: 1720294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular cloning and expression of Mycobacterium tuberculosis Aoyama B peptide antigen genes in Escherichia coli--a gene encoding 60 kD antigen (AT201) and immunological activity of recombinant peptides (15 and 60 kD)].
    Tanaka-Hayashi T; Tsuyuguchi T; Aoyama K; Okamura H; Nagata K; Tamura T; Yamamoto Y; Furuyama J; Komatsu T; Shin-Ka S
    Kekkaku; 1990 Aug; 65(8):507-17. PubMed ID: 2120504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular cloning, expression, purification and immunological characterization of three low-molecular weight proteins encoded by genes in genomic regions of difference of mycobacterium tuberculosis.
    Hanif SN; Al-Attiyah R; Mustafa AS
    Scand J Immunol; 2010 May; 71(5):353-61. PubMed ID: 20500686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and immunologic reactivity of a novel low molecular mass antigen of Mycobacterium tuberculosis.
    Coler RN; Skeiky YA; Vedvick T; Bement T; Ovendale P; Campos-Neto A; Alderson MR; Reed SG
    J Immunol; 1998 Sep; 161(5):2356-64. PubMed ID: 9725231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological characterization of novel secreted antigens of Mycobacterium tuberculosis.
    Ben Amor Y; Shashkina E; Johnson S; Bifani PJ; Kurepina N; Kreiswirth B; Bhattacharya S; Spencer J; Rendon A; Catanzaro A; Gennaro ML
    Scand J Immunol; 2005 Feb; 61(2):139-46. PubMed ID: 15683450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines against mycobacterial diseases.
    Romano M; Huygen K
    Expert Rev Vaccines; 2009 Sep; 8(9):1237-50. PubMed ID: 19722896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring functional genomics for the development of novel intervention strategies against tuberculosis.
    Rachman H; Kaufmann SH
    Int J Med Microbiol; 2007 Nov; 297(7-8):559-67. PubMed ID: 17467338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression systems for study of mycobacterial gene regulation and development of recombinant BCG vaccines.
    DasGupta SK; Jain S; Kaushal D; Tyagi AK
    Biochem Biophys Res Commun; 1998 May; 246(3):797-804. PubMed ID: 9618292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New ways to identify novel bacterial antigens for vaccine development.
    Movahedi AR; Hampson DJ
    Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.